Latest period
$554.13M
YoY change
+25.0%
5Y CAGR
+16.9%
Peak year (2025)
$1.75B
Latest annual
$1.75B
Operating Cash Flow history chart for ResMed (RMD) from 1993 to 2025
Latest: $1.75B
Operating Cash Flow growth chart for ResMed (RMD) from 1993 to 2025
Latest: +25.0%
Operating Cash Flow history table for ResMed (RMD) from 1993 to 2025
| 2025 | $1.75B | +25.0% | +$350.33M | ||
| 2024 | $1.40B | +102.1% | +$707.96M | ||
| 2023 | $693.30M | +97.4% | +$342.15M | ||
| 2022 | $351.15M | -52.3% | −$385.57M | ||
| 2021 | $736.72M | -8.2% | −$65.54M | ||
| 2020 | $802.25M | +74.8% | +$343.20M | ||
| 2019 | $459.05M | -9.1% | −$45.98M | ||
| 2018 | $505.03M | +22.0% | +$90.97M | ||
| 2017 | $414.05M | -24.4% | −$133.88M | ||
| 2016 | $547.93M | +43.0% | +$164.75M | ||
| 2015 | $383.18M | -2.1% | −$8.09M | ||
| 2014 | $391.27M | -2.9% | −$11.55M | ||
| 2013 | $402.82M | +5.1% | +$19.66M | ||
| 2012 | $383.16M | +35.3% | +$99.97M | ||
| 2011 | $283.19M | +50.5% | +$94.98M | ||
| 2010 | $188.21M | -21.2% | −$50.66M | ||
| 2009 | $238.88M | +73.3% | +$101.04M | ||
| 2008 | $137.84M | +51.3% | +$46.73M | ||
| 2007 | $91.11M | -8.0% | −$7.92M | ||
| 2006 | $99.03M | +39.3% | +$27.95M | ||
| 2005 | $71.08M | -7.1% | −$5.46M | ||
| 2004 | $76.54M | +29.1% | +$17.26M | ||
| 2003 | $59.28M | +66.3% | +$23.64M | ||
| 2002 | $35.64M | +20.7% | +$6.12M | ||
| 2001 | $29.52M | +45.6% | +$9.24M | ||
| 2000 | $20.27M | +11.4% | +$2.08M | ||
| 1999 | $18.20M | +167.6% | +$11.40M | ||
| 1998 | $6.80M | -28.4% | −$2.70M | ||
| 1997 | $9.50M | +171.4% | +$6.00M | ||
| 1996 | $3.50M | +400.0% | +$2.80M | ||
| 1995 | $700.00K | -56.3% | −$900.00K | ||
| 1994 | $1.60M | +60.0% | +$600.00K | ||
| 1993 | $1.00M | — | — |
- 2025$1.75B+25.0%
- 2024$1.40B+102.1%
- 2023$693.30M+97.4%
- 2022$351.15M-52.3%
- 2021$736.72M-8.2%
- 2020$802.25M+74.8%
- 2019$459.05M-9.1%
- 2018$505.03M+22.0%
- 2017$414.05M-24.4%
- 2016$547.93M+43.0%
- 2015$383.18M-2.1%
- 2014$391.27M-2.9%
- 2013$402.82M+5.1%
- 2012$383.16M+35.3%
- 2011$283.19M+50.5%
- 2010$188.21M-21.2%
- 2009$238.88M+73.3%
- 2008$137.84M+51.3%
- 2007$91.11M-8.0%
- 2006$99.03M+39.3%
- 2005$71.08M-7.1%
- 2004$76.54M+29.1%
- 2003$59.28M+66.3%
- 2002$35.64M+20.7%
- 2001$29.52M+45.6%
- 2000$20.27M+11.4%
- 1999$18.20M+167.6%
- 1998$6.80M-28.4%
- 1997$9.50M+171.4%
- 1996$3.50M+400.0%
- 1995$700.00K-56.3%
- 1994$1.60M+60.0%
- 1993$1.00M—
Operating Cash Flow values are taken from ResMed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at ResMed (RMD)
Operating Cash Flow for ResMed (RMD): headline value $554.13M · YoY +25.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of ResMed (RMD) operating cash flow is $1.75B – grew 25.0% year-over-year.
ResMed operating cash flow compound annual growth for the 2020–2025 (5 years) window is +16.9%, sustaining 3 straight years of year-over-year growth.
The record annual operating cash flow stands at $1.75B, reached in 2025; the historical low of $700.00K was recorded in 1995.
ResMed Operating Cash Flow by Year
ResMed Operating Cash Flow 2025: $1.75B
In 2025, ResMed reported operating cash flow of $1.75B, grew 25.0% from 2024. This figure represents the highest annual value in the available history.
ResMed Operating Cash Flow 2024: $1.40B
ResMed operating cash flow in 2024 was $1.40B, surged 102.1% from 2023.
ResMed Operating Cash Flow 2023: $693.30M
2023's operating cash flow for ResMed came in at $693.30M, surged 97.4% from 2022.
ResMed Operating Cash Flow 2022: $351.15M
ResMed posted operating cash flow of $351.15M in 2022, plunged 52.3% below 2021.
ResMed Operating Cash Flow 2021: $736.72M
ResMed operating cash flow in 2021 was $736.72M.
See more financial history for ResMed (RMD).
Sector peers by Operating Cash Flow
Healthcare peers of ResMed (RMD), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation